Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Rovira

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Journal of Neurology|September 18, 2014
N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosisAlessandro Trentini, Manuel Comabella, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2021
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysisPaola Valsasina, Claudio Gobbi, Chiara Zecca, et al.
Revista De Neurologia|June 11, 2014
Biomarkers in multiple sclerosis: an update for 2014Oscar Fernandez, Roland Martin, Alex Rovira, et al.
Multiple Sclerosis and Related Disorders|July 31, 2021
Drug-related demyelinating syndromes: understanding risk factors, pathophysiological mechanisms and magnetic resonance imaging findingsCarolina M Rimkus, Vinicius Andreoli Schoeps, Mateus Boaventura, et al.
Brain : a Journal of Neurology|February 1, 2013
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amilorideTarunya Arun, Valentina Tomassini, Emilia Sbardella, et al.
Neurobiology of Aging|April 13, 2010
ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathySophie Domingues-Montanari, Mar Hernandez-Guillamon, Israel Fernandez-Cadenas, et al.
Revista De Neurologia|November 5, 2011
[Spanish multi-centre observational study of the first attacks suggestive of multiple sclerosis: the PREM cohort]Jaume Sastre-Garriga, Alex Rovira, Inmaculada Bonaventura, et al.
Annals of Neurology|September 21, 2007
Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imagingOliver C Singer, Marek C Humpich, Jens Fiehler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 16, 2013
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changesAngela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
Annals of Neurology|April 3, 2008
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter studyZhaleh Khaleeli, Olga Ciccarelli, Francesco Manfredonia, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Journal of Neurology|September 18, 2014
N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosisAlessandro Trentini, Manuel Comabella, Mar Tintoré, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2021
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysisPaola Valsasina, Claudio Gobbi, Chiara Zecca, et al.
Revista De Neurologia|June 11, 2014
Biomarkers in multiple sclerosis: an update for 2014Oscar Fernandez, Roland Martin, Alex Rovira, et al.
Multiple Sclerosis and Related Disorders|July 31, 2021
Drug-related demyelinating syndromes: understanding risk factors, pathophysiological mechanisms and magnetic resonance imaging findingsCarolina M Rimkus, Vinicius Andreoli Schoeps, Mateus Boaventura, et al.
Brain : a Journal of Neurology|February 1, 2013
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amilorideTarunya Arun, Valentina Tomassini, Emilia Sbardella, et al.
Neurobiology of Aging|April 13, 2010
ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathySophie Domingues-Montanari, Mar Hernandez-Guillamon, Israel Fernandez-Cadenas, et al.
Revista De Neurologia|November 5, 2011
[Spanish multi-centre observational study of the first attacks suggestive of multiple sclerosis: the PREM cohort]Jaume Sastre-Garriga, Alex Rovira, Inmaculada Bonaventura, et al.
Annals of Neurology|September 21, 2007
Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imagingOliver C Singer, Marek C Humpich, Jens Fiehler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 16, 2013
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changesAngela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
Annals of Neurology|April 3, 2008
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter studyZhaleh Khaleeli, Olga Ciccarelli, Francesco Manfredonia, et al.
Pageof 20